There is real hope for treating spinal cord injury with stem cell-based therapies in the future. However, unfortunately regulators in Japan have taken a major misstep in approving a not-ready-for-primetime mesenchymal stem cell (MSC)-based approach to spinal cord injury. Their […]

The post Japan’s dangerous gamble approving unproven stem cells for spinal cord injury appeared first on The Niche.